OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
8
Results
Show all
Save search
Copy query
Show results for
Unknown
(8)
Publication Date
Release Date
2022
(3)
2025
(2)
2026
(1)
2024
(1)
2023
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
The association between serum S100β levels and prognosis in acute stroke patients after intravenous thrombolysis: a multicenter prospective cohort study.
Not available
S-EPMC11447957
|
biostudies-literature
Cite
Progression of Neuroinflammation Is Associated With Clinical Prognosis of Patients Undergoing Intravenous Thrombolysis.
Not available
S-EPMC12928816
|
biostudies-literature
Cite
A Novel Signature Integrated of Immunoglobulin, Glycosylation and Anti-Viral Genes to Predict Prognosis for Breast Cancer.
Not available
S-EPMC9011196
|
biostudies-literature
Cite
Stool-based methylated syndecan-2 testing has a high positive predictive value in an average/increased-risk population: a multicenter retrospective study.
Not available
S-EPMC12360836
|
biostudies-literature
Cite
Comparison of endovascular therapy care and outcome in primary and comprehensive stroke centers for acute ischemic stroke in China a real-world nationwide registry.
Not available
S-EPMC12641255
|
biostudies-literature
Cite
Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2.
Not available
S-EPMC10232969
|
biostudies-literature
Cite
Selection criteria for large core trials: rationale for the ANGEL-ASPECT study design.
Not available
S-EPMC8785010
|
biostudies-literature
Cite
Effect of Intravenous Tirofiban vs Placebo Before Endovascular Thrombectomy on Functional Outcomes in Large Vessel Occlusion Stroke: The RESCUE BT Randomized Clinical Trial.
Not available
S-EPMC9364124
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets